Borderline ovarian tumors have an excellent prognosis. In stage I disease, no therapy in
addition to surgery is needed, and conservation of ovarian tissue for future childbearing may …

To assess the clinical potential of serial serum CA125 measurements in the follow‐up of
patients with epithelial ovarian cancer, 74 consecutive unselected patients with …

Objective Stress-induced phosphoprotein 1 (STIP1) was recently identified as a potential
tumor marker for human ovarian cancer. This study further evaluates the usefulness of STIP1 …

Seventy four consecutive patients with epithelial ovarian cancer have been followed up
longitudinally with serial serum CA125 for up to 48 months. From this database, the CAl25 …

The majority of epithelial ovarian carcinomas (EOCs) are derived from the ovarian surface
epithelium (OSE). EOCs are the most lethal of all gynecological malignancies. Most patients …

The serum levels of tissue polypeptide-specific (TPS) antigen were measured using the M3
monoclonal antibody in an enzyme immunoassay in 33 patients with ovarian cancer, in 26 …

Serum CA 125 was evaluated as a tumor marker in 85 patients with borderline ovarian
tumors. Serum CA 125 levels were elevated preoperatively in 18 of 20 (90%) samples …

CA 125 was measured preoperatively in 184 female patients presenting with pelvic masses.
Ovarian tumors were diagnosed in 151 cases (91 carcinomas, eight borderline, 52 benign) …

BACKGROUND.: The serum CA-125 antigen value has proven to be useful in predicting
changes that affect prognosis and management of ovarian cancer; however, interpreting …

Preoperative levels of the trace elements copper and zinc, in addition to the level of the
known marker CA 125, were studied in sera of 32 patients undergoing exploratory …